Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17877398 | 0.91 | KMT2A (0.34) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17877397 | 0.77 | MEN1 (0.33) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17877393 | 0.77 | ALDH1A1 (0.37) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17877396 | 0.77 | ALDH1A1 (0.39) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17877394 | 0.77 | ALDH1A1 (0.39) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17877399 | 0.73 | HMGCR (0.38) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17877406 | 0.73 | HMGCR (0.38) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL20000741 | 0.73 | ALDH1A1 (0.41) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17877388 | 0.72 | GAA (0.38) | MEN1KMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL28798490 | 0.71 | KMT2A (0.47) | MEN1KMT2AGAAKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170038642-A1 | ALIGNMENT LAYER AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-09 | — | — | US | disclosed |
| US-20170038642-A1 | ALIGNMENT LAYER AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-09 | — | — | US | disclosed |
| US-20160185763-A1 | LIQUID CRYSTAL STABILIZER, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME, AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160185763-A1 | LIQUID CRYSTAL STABILIZER, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME, AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185763-A1 | LIQUID CRYSTAL STABILIZER, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME, AND LIQUID CRYSTAL DISPLAY INCLUDING THE SAME | PYM1, YBX3, MLX | MEN1 2562/4885KMT2A 2137/4885GAA 4819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.